Ernesto Londoño is a national correspondent with The New York Times, where he covers the U.S. midwest. He’s also ...

Psychiatric medicine hasn’t seen much innovation in recent decades, even as many say that drugs like psilocybin, MDMA, and ...

Two Toronto startups are developing psilocybin-based medications that could expand treatment options for those in need.

The drugs covered by the initiative would include hallucinogenic mushrooms, ayahuasca tea, and the plants from which the ...

After more than 10,000 years of use, the ancient cultures and indigenous communities who use plant medicines may hold lessons ...

The FDA rejected an application to approve MDMA, also known as ecstasy, as a treatment for PTSD. Next up among the ...

Massachusetts voters could legalize psychedelics and create a regulated-access model for treating mental health conditions.

While psychedelics like LSD and psilocybin are generally well tolerated in clinical and research settings, study authors ...

Interest in psychedelics from the Western world has been growing in the recent years, as more studies uncover the mental-health benefits ...

Supporters of a November ballot question to legalize the use and possession of some psychedelic substances in Massachusetts ...

Many patients face barriers when discussing the therapeutic use of psychedelics with doctors. Learn about the patient's ...

The DEA acknowledges a new two-part test for determining marijuana's accepted medical use, a significant shift as cannabis ...